Logo image of NAYA

NAYA BIOSCIENCES INC (NAYA) Stock Fundamental Analysis

NASDAQ:NAYA - Nasdaq - US44984F4019 - Common Stock - Currency: USD

2.2  +0.17 (+8.37%)

After market: 2.34 +0.14 (+6.36%)

Fundamental Rating

1

Overall NAYA gets a fundamental rating of 1 out of 10. We evaluated NAYA against 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of NAYA have multiple concerns. While showing a medium growth rate, NAYA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NAYA has reported negative net income.
NAYA had a negative operating cash flow in the past year.
In the past 5 years NAYA always reported negative net income.
NAYA had negative operating cash flow in 4 of the past 5 years.
NAYA Yearly Net Income VS EBIT VS OCF VS FCFNAYA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -43.87%, NAYA is not doing good in the industry: 64.55% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -43.87%
ROE N/A
ROIC N/A
ROA(3y)-122.53%
ROA(5y)-112.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAYA Yearly ROA, ROE, ROICNAYA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K

1.3 Margins

NAYA has a worse Gross Margin (42.40%) than 66.67% of its industry peers.
NAYA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NAYA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.71%
GM growth 5Y-15.12%
NAYA Yearly Profit, Operating, Gross MarginsNAYA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10K -20K -30K -40K

More info and screens

0

2. Health

2.1 Basic Checks

NAYA does not have a ROIC to compare to the WACC, probably because it is not profitable.
NAYA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NAYA has more shares outstanding
NAYA has a better debt/assets ratio than last year.
NAYA Yearly Shares OutstandingNAYA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
NAYA Yearly Total Debt VS Total AssetsNAYA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -6.38, we must say that NAYA is in the distress zone and has some risk of bankruptcy.
NAYA has a Altman-Z score of -6.38. This is in the lower half of the industry: NAYA underperforms 73.55% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.38
ROIC/WACCN/A
WACC6.25%
NAYA Yearly LT Debt VS Equity VS FCFNAYA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

NAYA has a Current Ratio of 0.23. This is a bad value and indicates that NAYA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.23, NAYA is not doing good in the industry: 95.77% of the companies in the same industry are doing better.
A Quick Ratio of 0.20 indicates that NAYA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.20, NAYA is doing worse than 96.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.2
NAYA Yearly Current Assets VS Current LiabilitesNAYA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.18% over the past year.
Looking at the last year, NAYA shows a very strong growth in Revenue. The Revenue has grown by 224.37%.
The Revenue has been growing by 43.87% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)76.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.06%
Revenue 1Y (TTM)224.37%
Revenue growth 3Y42.68%
Revenue growth 5Y43.87%
Sales Q2Q%47.75%

3.2 Future

NAYA is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -100.83% yearly.
NAYA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 101.26% yearly.
EPS Next Y-3770%
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%
EPS Next 5YN/A
Revenue Next Year125.23%
Revenue Next 2Y57.41%
Revenue Next 3Y39.68%
Revenue Next 5Y101.26%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NAYA Yearly Revenue VS EstimatesNAYA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
NAYA Yearly EPS VS EstimatesNAYA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -50 -100 -150 -200

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NAYA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NAYA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAYA Price Earnings VS Forward Price EarningsNAYA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAYA Per share dataNAYA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

A cheap valuation may be justified as NAYA's earnings are expected to decrease with -100.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NAYA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NAYA BIOSCIENCES INC

NASDAQ:NAYA (4/25/2025, 8:25:39 PM)

After market: 2.34 +0.14 (+6.36%)

2.2

+0.17 (+8.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)05-13 2025-05-13
Inst Owners2.88%
Inst Owner ChangeN/A
Ins Owners1.05%
Ins Owner ChangeN/A
Market Cap1.47M
Analysts82.86
Price Target6.12 (178.18%)
Short Float %N/A
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)200%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-7640%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.96
EYN/A
EPS(NY)-2.45
Fwd EYN/A
FCF(TTM)-4.85
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS9.3
BVpS-0.03
TBVpS-14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.87%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.4%
FCFM N/A
ROA(3y)-122.53%
ROA(5y)-112.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.71%
GM growth 5Y-15.12%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.66%
Cap/Sales 2.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.2
Altman-Z -6.38
F-Score3
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)577.95%
Cap/Depr(5y)746.77%
Cap/Sales(3y)8.92%
Cap/Sales(5y)8.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.06%
EPS Next Y-3770%
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%
EPS Next 5YN/A
Revenue 1Y (TTM)224.37%
Revenue growth 3Y42.68%
Revenue growth 5Y43.87%
Sales Q2Q%47.75%
Revenue Next Year125.23%
Revenue Next 2Y57.41%
Revenue Next 3Y39.68%
Revenue Next 5Y101.26%
EBIT growth 1Y29.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.79%
OCF growth 3YN/A
OCF growth 5YN/A